SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-031640
Filing Date
2021-12-15
Accepted
2021-12-15 21:04:57
Documents
2
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4702
2 ex24-1.htm EX-24.1 20335
  Complete submission text file 0001493152-21-031640.txt   26388
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Issuer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064
Business Address
Hsu Jason (Reporting) CIK: 0001895035 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41159 | Film No.: 211495716